Structure of BBD
CAS No.: 18378-20-6
*Storage: {[sel_prStorage]}
*Shipping: {[sel_prShipping]}
The BI-3802 was designed by Boehringer Ingelheim and could be obtained free of charge through the Boehringer Ingelheim open innovation portal opnMe.com, associated with its negative control.
BBD is a biochemical reagent/chromogenic reagent.
Synonyms: NSC240867; Benzylamino-NBD
4.5
*For Research Use Only !
Change View
Size | Price | VIP Price | US Stock |
Global Stock |
In Stock | ||
{[ item.pr_size ]} |
Inquiry
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.discount_usd) ]} {[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} |
Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]} | Inquiry {[ item.pr_usastock ]} In Stock Inquiry - | {[ item.pr_chinastock ]} {[ item.pr_remark ]} In Stock 1-2 weeks - Inquiry - | Login | - + | Inquiry |
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
1-2weeks
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price, item.pr_usd) ]}
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
In Stock
- +
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
CAS No. : | 18378-20-6 |
Formula : | C13H10N4O3 |
M.W : | 270.24 |
SMILES Code : | O=[N+](C1=CC=C(NCC2=CC=CC=C2)C3=NON=C31)[O-] |
Synonyms : |
NSC240867; Benzylamino-NBD
|
MDL No. : | MFCD00038006 |
InChI Key : | GZFKJMWBKTUNJS-UHFFFAOYSA-N |
Pubchem ID : | 87615 |
GHS Pictogram: |
![]() |
Signal Word: | Warning |
Hazard Statements: | H315-H319-H335 |
Precautionary Statements: | P261-P305+P351+P338 |
In Vitro:
Cell Line
|
Concentration | Treated Time | Description | References |
BV-2 cells | 1 to 20 μM | 30 minutes | To assess the inhibitory effect of BBD on hypoxia-induced inflammatory responses. BBD significantly reduced ROS accumulation, IL-1, IL-6, and PGE2 production, and inhibited the activation of JNK MAPK, COX-2, and caspase-3. | PMC3975964 |
PC12 cells | 1 to 20 μM | 30 minutes | To evaluate the protective effect of BBD against hypoxia-induced cytotoxicity. BBD at concentrations of 1 to 20 μM significantly increased cell viability and reduced LDH release in PC12 cells. | PMC3975964 |
Clinical Trial:
NCT Number | Conditions | Phases | Recruitment | Completion Date | Locations |
NCT03464955 | Stress, Emotional ... More >> Stress, Psychological Behavioral Symptoms Less << | Not Applicable | Recruiting | October 16, 2019 | United States, California ... More >> Lucile Packard Children's Hospital at Stanford Recruiting Palo Alto, California, United States, 94304 Contact: Sam Rodriguez, MD 650-723-5728 sr1@stanford.edu Contact: Tom J Caruso 650-723-5728 tjcaruso@stanford.edu Principal Investigator: Sam Rodriguez, MD Sub-Investigator: Tom J Caruso, MD Less << |
NCT02597764 | Bladder and Bowel Disorder, Pe... More >>diatric Less << | Not Applicable | Completed | - | Canada, British Columbia ... More >> BC Children's and Women's Hospital Vancouver, British Columbia, Canada, V6H 3N1 Less << |
NCT03220828 | Stress, Emotional | Not Applicable | Recruiting | May 11, 2019 | United States, California ... More >> Lucile Packard Children's Hospital at Stanford Recruiting Palo Alto, California, United States, 94304 Contact: Sam Rodriguez, MD 650-723-5728 sr1@stanford.edu Contact: Tom J Caruso 650-723-5728 tjcaruso@stanford.edu Principal Investigator: Sam Rodriguez, MD Sub-Investigator: Tom J Caruso, MD Less << |
NCT01308450 | - | Completed | - | - | |
NCT01308450 | - | Completed | - | United States, Utah ... More >> The Focus Center Clinton, Utah, United States, 84015 Less << | |
NCT01118650 | - | Withdrawn(No interest from sch... More >>ool district) Less << | - | - | |
NCT02432625 | - | Recruiting | June 2025 | United States, California ... More >> University of California Los Angeles Recruiting Los Angeles, California, United States, 90095 Contact: Samantha Alon 310-794-6420 SAlon@mednet.ucla.edu Principal Investigator: Deborah Krakow, MD United States, District of Columbia Children's National Medical Center Recruiting Washington, District of Columbia, United States, 21205 Contact: Christina Dollar cdollar@childrensnational.org Contact: Austin Gillies ausgillies@gmail.com Principal Investigator: Laura Tosi, MD United States, Florida Tampa Shriners Hospital for Children Recruiting Tampa, Florida, United States, 33612 Contact: Margaret Gross-King 813-972-2250 ext 7538 mgking@shrinenet.org Principal Investigator: Danielle Gomez, MD United States, Maryland Kennedy Krieger Institute / Hugo W. Moser Research Institute Recruiting Baltimore, Maryland, United States, 21205 Contact: Jennifer Nagy, RN, BSN 443-923-2704 Nagy@kennedykrieger.org Principal Investigator: Mahim Jain, MD United States, Nebraska University of Nebraska Medical Center Recruiting Omaha, Nebraska, United States, 68198 Contact: Elizabeth Strudthoff, B.S. 402-559-0681 elizabeth.strudthoff@unmc.edu Principal Investigator: Paul Esposito, MD United States, New York Hospital for Special Surgery Recruiting New York, New York, United States, 10021 Contact: Sobiah Khan 212-774-2355 KhanS@HSS.EDU Principal Investigator: Cathleen Raggio, MD United States, Oregon Oregon Health and Science University Recruiting Portland, Oregon, United States, 97239 Contact: Catherine Pederson 503-494-0225 pedersec@ohsu.edu Principal Investigator: Eric Orwoll, MD United States, Texas Baylor College of Medicine Recruiting Houston, Texas, United States, 77030 Contact: Dianne Dang 713-798-6694 diannen@bcm.edu Principal Investigator: V.Reid Sutton, MD United States, Wisconsin Shriners Hospital for Children, Chicago / Marquette University Recruiting Milwaukee, Wisconsin, United States, 53201 Contact: Angela Caudill, MPT 773-385-5868 acaudill@shrinenet.org Principal Investigator: Peter Smith, MD Canada, Quebec Shriners Hospital for Children Recruiting Montreal, Quebec, Canada, H3G 1A6 Contact: Michaela Durigova 514-282-7158 mdurigova@shriners.mcgill.ca Principal Investigator: Frank Rauch, MD Sub-Investigator: Francis Glorieux, MD Less << | |
NCT02424851 | Multiple Myeloma ... More >> Chronic Kidney Disease Less << | Phase 2 | Recruiting | June 2019 | United Kingdom ... More >> Basingstoke & North Hampshire Hospital Not yet recruiting Basingstoke, United Kingdom Principal Investigator: Noel Ryman Kent & Canterbury Hospital Recruiting Canterbury, United Kingdom, CT1 3NG Principal Investigator: Jindrinska Lindsay St Helier Hospital Recruiting Epsom, United Kingdom Principal Investigator: Simon Stern Royal Liverpool Hospital Recruiting Liverpool, United Kingdom Principal Investigator: Nauman Butt Churchill Hospital Recruiting Oxford, United Kingdom, OX3 7LE Principal Investigator: Karthik Ramasamy Queen Alexandra Hospital Recruiting Portsmouth, United Kingdom Contact: Helen Dignum Principal Investigator: Helen Dignum Great Western Hospital Suspended Swindon, United Kingdom Less << |
NCT00000231 | Opioid-Related Disorders | Phase 2 | Completed | - | United States, Vermont ... More >> Treatment Research Center Burlington, Vermont, United States, 05401 Less << |
NCT00000230 | Opioid-Related Disorders | Phase 2 | Completed | - | United States, Vermont ... More >> Treatment Research Center Burlington, Vermont, United States, 05401 Less << |
NCT03072303 | - | Active, not recruiting | June 30, 2019 | United States, Florida ... More >> RDCRN Data Management and Coordinating Center, University of South Florida Tampa, Florida, United States, 33612 Less << | |
NCT00000228 | Opioid-Related Disorders | Phase 2 | Completed | - | United States, Vermont ... More >> Treatment Research Center Burlington, Vermont, United States, 05401 Less << |
NCT00000229 | Opioid-Related Disorders | Phase 2 | Completed | - | United States, Vermont ... More >> Treatment Research Center Burlington, Vermont, United States, 05401 Less << |
NCT02793063 | - | Completed | - | United States, Florida ... More >> University of South Florida, Health Informatics Institute Tampa, Florida, United States, 33612 Less << | |
NCT01056276 | Multiple Myeloma | Phase 2 | Completed | - | United States, California ... More >> Los Robles Hospital and Medical Center Thousand Oaks, California, United States, 91360 United States, Florida Florida Cancer Specialists Ft. Myers, Florida, United States, 33916 United States, Louisiana Hematology Oncology Clinic, LLP Baton Rouge, Louisiana, United States, 70809 United States, Maryland Center for Cancer and Blood Disorders Bethesda, Maryland, United States, 20817 National Capital Clinical Research Consortium Bethesda, Maryland, United States, 20817 United States, Michigan Grand Rapids Clinical Oncology Program Grand Rapids, Michigan, United States, 49503 United States, Ohio Oncology Hematology Care Inc. Cincinnati, Ohio, United States, 45242 United States, South Carolina South Carolina Oncology Associates Columbia, South Carolina, United States, 29210 United States, Tennessee Chattanooga Oncology Hematology Associates Chattanooga, Tennessee, United States, 37404 Tennessee Oncology Nashville, Tennessee, United States, 37203 United States, Texas Leading Edge Research, PA Arlington, Texas, United States, 75213 The Center for Cancer and Blood Disorders Fort Worth, Texas, United States, 76104 United States, Virginia Peninsula Cancer Institute Newport News, Virginia, United States, 23601 Less << |
NCT01056276 | - | Completed | - | - | |
NCT02224729 | Stage I Multiple Myeloma ... More >> Stage II Multiple Myeloma Stage III Multiple Myeloma Less << | Phase 2 | Active, not recruiting | January 2020 | United States, Pennsylvania ... More >> Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 Less << |
NCT02224729 | - | Active, not recruiting | - | - | |
NCT01168804 | Multiple Myeloma | Phase 2 | Completed | - | Austria ... More >> Medical University Hospital Graz Graz, Austria, 8036 Hospital Elisabethinen Linz Linz, Austria, 4010 LKH Salzburg, 3rd Med. Dept. Salzburg, Austria, 5020 Med. University Vienna, Clinic for Internal Medicine 1 (Hematology and Hemostaseology) Vienna, Austria, 1090 Hanusch Hospital Vienna Vienna, Austria, 1140 Wilhelminenspital Vienna Vienna, Austria, 1160 Clinic Wels-Grieskirchen, 4th Internal Dept. Wels, Austria, 4600 Czech Republic Faculty Hospital Brno Brno, Czech Republic, 63900 Less << |
Bio Calculators | ||||
Preparing Stock Solutions | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
3.70mL 0.74mL 0.37mL |
18.50mL 3.70mL 1.85mL |
37.00mL 7.40mL 3.70mL |
Tags: BBD | NSC240867 | 18378-20-6
Precautionary Statements-General | |
Code | Phrase |
P101 | If medical advice is needed,have product container or label at hand. |
P102 | Keep out of reach of children. |
P103 | Read label before use |
Prevention | |
Code | Phrase |
P201 | Obtain special instructions before use. |
P202 | Do not handle until all safety precautions have been read and understood. |
P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
P211 | Do not spray on an open flame or other ignition source. |
P220 | Keep/Store away from clothing/combustible materials. |
P221 | Take any precaution to avoid mixing with combustibles |
P222 | Do not allow contact with air. |
P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
P230 | Keep wetted |
P231 | Handle under inert gas. |
P232 | Protect from moisture. |
P233 | Keep container tightly closed. |
P234 | Keep only in original container. |
P235 | Keep cool |
P240 | Ground/bond container and receiving equipment. |
P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
P242 | Use only non-sparking tools. |
P243 | Take precautionary measures against static discharge. |
P244 | Keep reduction valves free from grease and oil. |
P250 | Do not subject to grinding/shock/friction. |
P251 | Pressurized container: Do not pierce or burn, even after use. |
P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
P262 | Do not get in eyes, on skin, or on clothing. |
P263 | Avoid contact during pregnancy/while nursing. |
P264 | Wash hands thoroughly after handling. |
P265 | Wash skin thouroughly after handling. |
P270 | Do not eat, drink or smoke when using this product. |
P271 | Use only outdoors or in a well-ventilated area. |
P272 | Contaminated work clothing should not be allowed out of the workplace. |
P273 | Avoid release to the environment. |
P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
P281 | Use personal protective equipment as required. |
P282 | Wear cold insulating gloves/face shield/eye protection. |
P283 | Wear fire/flame resistant/retardant clothing. |
P284 | Wear respiratory protection. |
P285 | In case of inadequate ventilation wear respiratory protection. |
P231 + P232 | Handle under inert gas. Protect from moisture. |
P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
Code | Phrase |
P301 | IF SWALLOWED: |
P304 | IF INHALED: |
P305 | IF IN EYES: |
P306 | IF ON CLOTHING: |
P307 | IF exposed: |
P308 | IF exposed or concerned: |
P309 | IF exposed or if you feel unwell: |
P310 | Immediately call a POISON CENTER or doctor/physician. |
P311 | Call a POISON CENTER or doctor/physician. |
P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
P313 | Get medical advice/attention. |
P314 | Get medical advice/attention if you feel unwell. |
P315 | Get immediate medical advice/attention. |
P320 | |
P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
P321 | |
P322 | |
P330 | Rinse mouth. |
P331 | Do NOT induce vomiting. |
P332 | IF SKIN irritation occurs: |
P333 | If skin irritation or rash occurs: |
P334 | Immerse in cool water/wrap n wet bandages. |
P335 | Brush off loose particles from skin. |
P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
P337 | If eye irritation persists: |
P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P342 | If experiencing respiratory symptoms: |
P350 | Gently wash with plenty of soap and water. |
P351 | Rinse cautiously with water for several minutes. |
P352 | Wash with plenty of soap and water. |
P353 | Rinse skin with water/shower. |
P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
P361 | Remove/Take off immediately all contaminated clothing. |
P362 | Take off contaminated clothing and wash before reuse. |
P363 | Wash contaminated clothing before reuse. |
P370 | In case of fire: |
P371 | In case of major fire and large quantities: |
P372 | Explosion risk in case of fire. |
P373 | DO NOT fight fire when fire reaches explosives. |
P374 | Fight fire with normal precautions from a reasonable distance. |
P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
P378 | |
P380 | Evacuate area. |
P381 | Eliminate all ignition sources if safe to do so. |
P390 | Absorb spillage to prevent material damage. |
P391 | Collect spillage. Hazardous to the aquatic environment |
P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
P370 + P376 | In case of fire: Stop leak if safe to Do so. |
P370 + P378 | In case of fire: |
P370 + P380 | In case of fire: Evacuate area. |
P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
Code | Phrase |
P401 | |
P402 | Store in a dry place. |
P403 | Store in a well-ventilated place. |
P404 | Store in a closed container. |
P405 | Store locked up. |
P406 | Store in corrosive resistant/ container with a resistant inner liner. |
P407 | Maintain air gap between stacks/pallets. |
P410 | Protect from sunlight. |
P411 | |
P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
P413 | |
P420 | Store away from other materials. |
P422 | |
P402 + P404 | Store in a dry place. Store in a closed container. |
P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
P403 + P235 | Store in a well-ventilated place. Keep cool. |
P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
P411 + P235 | Keep cool. |
Disposal | |
Code | Phrase |
P501 | Dispose of contents/container to ... |
P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
Code | Phrase |
H200 | Unstable explosive |
H201 | Explosive; mass explosion hazard |
H202 | Explosive; severe projection hazard |
H203 | Explosive; fire, blast or projection hazard |
H204 | Fire or projection hazard |
H205 | May mass explode in fire |
H220 | Extremely flammable gas |
H221 | Flammable gas |
H222 | Extremely flammable aerosol |
H223 | Flammable aerosol |
H224 | Extremely flammable liquid and vapour |
H225 | Highly flammable liquid and vapour |
H226 | Flammable liquid and vapour |
H227 | Combustible liquid |
H228 | Flammable solid |
H229 | Pressurized container: may burst if heated |
H230 | May react explosively even in the absence of air |
H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
H240 | Heating may cause an explosion |
H241 | Heating may cause a fire or explosion |
H242 | Heating may cause a fire |
H250 | Catches fire spontaneously if exposed to air |
H251 | Self-heating; may catch fire |
H252 | Self-heating in large quantities; may catch fire |
H260 | In contact with water releases flammable gases which may ignite spontaneously |
H261 | In contact with water releases flammable gas |
H270 | May cause or intensify fire; oxidizer |
H271 | May cause fire or explosion; strong oxidizer |
H272 | May intensify fire; oxidizer |
H280 | Contains gas under pressure; may explode if heated |
H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
H290 | May be corrosive to metals |
Health hazards | |
Code | Phrase |
H300 | Fatal if swallowed |
H301 | Toxic if swallowed |
H302 | Harmful if swallowed |
H303 | May be harmful if swallowed |
H304 | May be fatal if swallowed and enters airways |
H305 | May be harmful if swallowed and enters airways |
H310 | Fatal in contact with skin |
H311 | Toxic in contact with skin |
H312 | Harmful in contact with skin |
H313 | May be harmful in contact with skin |
H314 | Causes severe skin burns and eye damage |
H315 | Causes skin irritation |
H316 | Causes mild skin irritation |
H317 | May cause an allergic skin reaction |
H318 | Causes serious eye damage |
H319 | Causes serious eye irritation |
H320 | Causes eye irritation |
H330 | Fatal if inhaled |
H331 | Toxic if inhaled |
H332 | Harmful if inhaled |
H333 | May be harmful if inhaled |
H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
H335 | May cause respiratory irritation |
H336 | May cause drowsiness or dizziness |
H340 | May cause genetic defects |
H341 | Suspected of causing genetic defects |
H350 | May cause cancer |
H351 | Suspected of causing cancer |
H360 | May damage fertility or the unborn child |
H361 | Suspected of damaging fertility or the unborn child |
H361d | Suspected of damaging the unborn child |
H362 | May cause harm to breast-fed children |
H370 | Causes damage to organs |
H371 | May cause damage to organs |
H372 | Causes damage to organs through prolonged or repeated exposure |
H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
Code | Phrase |
H400 | Very toxic to aquatic life |
H401 | Toxic to aquatic life |
H402 | Harmful to aquatic life |
H410 | Very toxic to aquatic life with long-lasting effects |
H411 | Toxic to aquatic life with long-lasting effects |
H412 | Harmful to aquatic life with long-lasting effects |
H413 | May cause long-lasting harmful effects to aquatic life |
H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :
Total Compounds: mg
The concentration of the dissolution solution you need to prepare is mg/mL